IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Synergy Pharmaceuticals Inc

Q4 2024 vs Q1 2025

Comparing institutional holders between quarters

Quarters

Q1 2025Q4 2024Q3 2024Q2 2024Q3 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
1620 Investment Advisors, Inc.
UNCHANGED
Shares25 from 25
Change0 (0%)
Value$0 ($0)
Filed 2025-05-14
Status
1620 Investment Advisors, Inc.
UNCHANGED252500%$0$0$02025-05-14
Showing 1 of 1 institutions